BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 22284156)

  • 1. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data.
    Romero R; Nicolaides K; Conde-Agudelo A; Tabor A; O'Brien JM; Cetingoz E; Da Fonseca E; Creasy GW; Klein K; Rode L; Soma-Pillay P; Fusey S; Cam C; Alfirevic Z; Hassan SS
    Am J Obstet Gynecol; 2012 Feb; 206(2):124.e1-19. PubMed ID: 22284156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Nicolaides KH
    Am J Obstet Gynecol; 2018 Feb; 218(2):161-180. PubMed ID: 29157866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study.
    Romero R; Nicolaides KH; Conde-Agudelo A; O'Brien JM; Cetingoz E; Da Fonseca E; Creasy GW; Hassan SS
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):308-17. PubMed ID: 27444208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.
    Hassan SS; Romero R; Vidyadhari D; Fusey S; Baxter JK; Khandelwal M; Vijayaraghavan J; Trivedi Y; Soma-Pillay P; Sambarey P; Dayal A; Potapov V; O'Brien J; Astakhov V; Yuzko O; Kinzler W; Dattel B; Sehdev H; Mazheika L; Manchulenko D; Gervasi MT; Sullivan L; Conde-Agudelo A; Phillips JA; Creasy GW;
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):18-31. PubMed ID: 21472815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
    Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH
    Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.
    Dodd JM; Grivell RM; OBrien CM; Dowswell T; Deussen AR
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012024. PubMed ID: 29086920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.
    Conde-Agudelo A; Romero R
    Am J Obstet Gynecol; 2016 Feb; 214(2):235-242. PubMed ID: 26450404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.
    Dodd JM; Grivell RM; OBrien CM; Dowswell T; Deussen AR
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31745984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in twin gestations: a systematic review and meta-analysis.
    Conde-Agudelo A; Romero R; Rehal A; Brizot ML; Serra V; Da Fonseca E; Cetingoz E; Syngelaki A; Perales A; Hassan SS; Nicolaides KH
    Am J Obstet Gynecol; 2023 Dec; 229(6):599-616.e3. PubMed ID: 37196896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.
    Martinez de Tejada B; Karolinski A; Ocampo MC; Laterra C; Hösli I; Fernández D; Surbek D; Huespe M; Drack G; Bunader A; Rouillier S; López de Degani G; Seidenstein E; Prentl E; Antón J; Krähenmann F; Nowacki D; Poncelas M; Nassif JC; Papera R; Tuma C; Espoile R; Tiberio O; Breccia G; Messina A; Peker B; Schinner E; Mol BW; Kanterewicz L; Wainer V; Boulvain M; Othenin-Girard V; Bertolino MV; Irion O;
    BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis.
    Conde-Agudelo A; Romero R; Nicolaides K; Chaiworapongsa T; O'Brien JM; Cetingoz E; da Fonseca E; Creasy G; Soma-Pillay P; Fusey S; Cam C; Alfirevic Z; Hassan SS
    Am J Obstet Gynecol; 2013 Jan; 208(1):42.e1-42.e18. PubMed ID: 23157855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal progesterone pessaries for pregnant women with a previous preterm birth to prevent neonatal respiratory distress syndrome (the PROGRESS Study): A multicentre, randomised, placebo-controlled trial.
    Crowther CA; Ashwood P; McPhee AJ; Flenady V; Tran T; Dodd JM; Robinson JS;
    PLoS Med; 2017 Sep; 14(9):e1002390. PubMed ID: 28949973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials.
    Suhag A; Saccone G; Berghella V
    Am J Obstet Gynecol; 2015 Oct; 213(4):479-87. PubMed ID: 25797233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials.
    EPPPIC Group
    Lancet; 2021 Mar; 397(10280):1183-1194. PubMed ID: 33773630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options and recommendations to reduce preterm births in women with short cervix.
    Slager J; Lynne S
    J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal progesterone vs intramuscular 17α-hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: systematic review and meta-analysis of randomized controlled trials.
    Saccone G; Khalifeh A; Elimian A; Bahrami E; Chaman-Ara K; Bahrami MA; Berghella V
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):315-321. PubMed ID: 27546354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical pessary for preventing preterm birth in singleton pregnancies.
    Abdel-Aleem H; Shaaban OM; Abdel-Aleem MA; Aboelfadle Mohamed A
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD014508. PubMed ID: 36453699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth.
    Dodd JM; Jones L; Flenady V; Cincotta R; Crowther CA
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD004947. PubMed ID: 23903965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone to prevent spontaneous preterm birth.
    Romero R; Yeo L; Chaemsaithong P; Chaiworapongsa T; Hassan SS
    Semin Fetal Neonatal Med; 2014 Feb; 19(1):15-26. PubMed ID: 24315687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.